Sartorius Stedim Biotech S.A.
SRTOY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $214,448,819 | $20,368,058 | $18,840,887 | $18,364,465 |
| - Cash | $350,973 | $699,300 | $707,600 | $678,900 |
| + Debt | $3,011,525 | $2,969,300 | $2,932,800 | $2,869,600 |
| Enterprise Value | $217,109,371 | $22,638,058 | $21,066,087 | $20,555,165 |
| Revenue | $824,644 | $745,000 | $744,600 | $751,300 |
| % Growth | 10.7% | 0.1% | -0.9% | – |
| Gross Profit | $382,583 | $344,700 | $356,300 | $316,300 |
| % Margin | 46.4% | 46.3% | 47.9% | 42.1% |
| EBITDA | $254,393 | $201,400 | $256,200 | $132,700 |
| % Margin | 30.8% | 27% | 34.4% | 17.7% |
| Net Income | $75,021 | $68,500 | $85,600 | $45,600 |
| % Margin | 9.1% | 9.2% | 11.5% | 6.1% |
| EPS Diluted | 0.008 | 0.069 | 0.088 | 0.047 |
| % Growth | -88.8% | -21.6% | 87.2% | – |
| Operating Cash Flow | $77,367 | $124,900 | $119,800 | $284,900 |
| Capital Expenditures | -$157,579 | -$75,900 | -$65,300 | -$80,000 |
| Free Cash Flow | -$80,212 | $49,000 | $54,500 | $204,900 |